Related Experiment Video

Updated: May 26, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

[Comparision of costs of secondary prevention and treatment of stroke--cost-effectiveness analysis]

Ivana Ceronja1, Zvonko Sosić

  • 1Zavod za javno zdravstvo Bjelovarsko-bilogorske zupanije, Bjelovar. iceronja@gmail.com

Lijecnicki Vjesnik
|December 15, 2011
PubMed

Insights

Secondary prevention of cerebrovascular accident (CVA) is cost-effective. Treating hypertension prevents costly CVAs, improving patient quality of life and long-term outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Economics

Background:

  • Untreated arterial hypertension is a significant risk factor for cerebrovascular accident (CVA).
  • Economic evaluation of healthcare interventions is crucial for resource allocation.

Purpose of the Study:

  • To compare the cost-effectiveness of secondary prevention strategies for CVA in patients with untreated arterial hypertension versus direct CVA treatment.
  • To analyze the long-term economic impact of hypertension management on CVA incidence.

Main Methods:

  • Cost-effectiveness analysis was employed.
  • Diagnosis and therapy costs for arterial hypertension were compared against CVA treatment costs.

Main Results:

  • The 30-year cost of secondary CVA prevention per patient was 15,107.75 kunas, factoring in a discount.
  • A single CVA treatment averaged 17,207.54 kunas.
  • Preventing one CVA through hypertension treatment (NNT=850) incurred a cost of 1,350,811.5 kunas, exceeding the cost of a single CVA treatment.

Conclusions:

  • Secondary prevention of CVA offers long-term patient benefits, including improved quality of life and reduced disability.
  • Primary and secondary prevention of hypertension provide greater overall advantages for patient well-being compared to treating established CVA.
Abstract

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Related Concept Videos

Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include: